Adaptas Solutions to Acquire Applied Kilovolts and Analytical Instrumentation Business from L3Harris Technologies
Adaptas Solutions, LLC. and L3Harris Technologies have signed a definitive agreement for Adaptas to acquire L3Harris' Applied Kilovolts and Analytical Instrumentation business.
In addition, Wave Neuroscience has acquired the Neuro-EEG Synchronization Therapy (NEST®) system developed and tested by NeoSync.
This acquisition, concluded in late January, further enhances ICON’s Medical Device and Diagnostic Research Services, through the addition of new regulatory and clinical capabilities in Europe.
This business unit acquisition advances Perry Baromedical into new international markets and expands the installed base in the US and abroad.
The acquisition of Digital Surgery will strengthen the Medtronic robotic-assisted surgery platform and has applicability for the Medtronic broader portfolio. The terms of the agreement are not being disclosed.
Bactiguard deepens the partnership that was initiated in 2015 by acquiring Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz) in Malaysia. The acquisition strengthens Bactiguard’s position in infection control and wound management, as well as innovation and product development capability and capacity. The consideration consists of a cash payment of USD 4.5 million payable at closing and, subject to approval by the annual general meeting of shareholders (AGM), 241 512 new class B-shares in Bactiguard, equivalent to a value of USD 2 million.
Medical technology company emphasizes commitment to value-based healthcare by combining electronic patient-reported outcomes (ePRO) with registries, treatment planning and image data generated by its software tools